← Back to headlines
Deadline Nears for ImmunityBio Investors in Securities Case
Investors of ImmunityBio, Inc. (NASDAQ: IBRX) are advised that a deadline is approaching to contact Kaplan Fox regarding potential securities violations.
20 Apr, 23:53 — 20 Apr, 23:53
Related Stories
Cornerstone Funds Declare Monthly Dividends and Announce 2026/2027 Distributions
3h ago
The OLB Group Reports Q2 Financials; FinVolution Group to Announce Results
5h ago
Mark Cuban and Tech Founders Oppose California Wealth Tax Proposal
7h ago
Greece to Save €2 Billion by Early Debt Repayment in 2026
8h ago